𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human fetal thymus and bone marrow contain target cells for natural killer cells

✍ Scribed by Mona Hansson; Rolf Kiessling; Börje Andersson


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
525 KB
Volume
11
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Strong natural killer (NK) cell activity
✍ Atsushi Uchida; Masato Yagita; Hiroyuki Sugiyama; Takashi Hoshino; Michael Moore 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 760 KB

Bone marrow natural killer (NK) cell activity was lopoiesis and possibly in vivo hematopoiesis (Hansson studied in patients with multiple myeloma. Bone marrow et a[., 1982; Lotzo\ra et al,, 1979). mononuclear cells from myeloma patients expressed consjde.b levels of cytotoxicity K562 i n a , , s~=,

Characterization of a type-C virus produ
✍ R. Guy Smith; Kees Nooter; Peter Bentvelzen; M. Robert-Guroff; K. Harewood; M. S 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 French ⚖ 752 KB

## Abstract The putative human helper virus SKA‐21/A204V, isolated by Nooter __et aal__. in 1977 from human leukemic bone‐marrow cells following co‐culture with normal fetal canine thymus cells, Cf2th, has been characterized with respect to its major viral core protein, reverse transcriptase, and n

Ganglioside gm2 as a target structure re
✍ Iwao Ando; Dave B. Hoon; Sidney H. Golub; Rieko F. Irie; Paul K. Pattengale 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

This report investigates the possibility that the ganglioside GM2 is a common target structure for natural killer cells. A subpop-ulation of lymphocytes, NK cells may play a role in vivo in controlling the growth of certain tumors.

Modulation of target cell susceptibility
✍ M. Moore; Wendy J. White; M. R. Potter 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 693 KB

## Abstract The spontaneous cytolytic activity of human peripheral blood lymphocytes in a short‐term ^51^chromium release assay was markedly enhanced by pretreatment with partially purified “Namalva” lymphoblastoid (type I)interferon (IF), provided that the target cells, five lymphoblastoid cell li